Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.
2.

Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori.

Fischbach W, Goebeler-Kolve M, Starostik P, Greiner A, Müller-Hermelink HK.

Lancet. 2002 Aug 17;360(9332):547-8.

PMID:
12241663
3.

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.

Hematol J. 2000;1(1):53-66.

PMID:
11920170
4.

Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways.

Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, Müller-Hermelink HK.

Blood. 2002 Jan 1;99(1):3-9.

5.

Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.

Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, Yao T, Tsuneyoshi M, Iida M, Fujishima M.

Gut. 2001 Apr;48(4):454-60.

6.

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.

Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, Isaacson PG.

Lancet. 2001 Jan 6;357(9249):39-40.

PMID:
11197361
7.

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

Ruskoné-Fourmestraux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A, Molina T, Rambaud JL.

Gut. 2001 Mar;48(3):297-303.

8.

Primary gastric lymphoma of MALT: considerations of pathogenesis, diagnosis and therapy.

Fischbach W.

Can J Gastroenterol. 2000 Nov;14 Suppl D:44D-50D. Review.

PMID:
11110611
9.

Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group.

Fischbach W, Dragosics B, Kolve-Goebeler ME, Ohmann C, Greiner A, Yang Q, Böhm S, Verreet P, Horstmann O, Busch M, Dühmke E, Müller-Hermelink HK, Wilms K, Allinger S, Bauer P, Bauer S, Bender A, Brandstätter G, Chott A, Dittrich C, Erhart K, Eysselt D, Ellersdorfer H, Ferlitsch A, Fridrik MA, Gartner A, Hausmaninger M, Hinterberger W, Hügel K, Ilsinger P, Jonaus K, Judmaier G, Karner J, Kerstan E, Knoflach P, Lenz K, Kandutsch A, Lobmeyer M, Michlmeier H, Mach H, Marosi C, Ohlinger W, Oprean H, Pointer H, Pont J, Salabon H, Samec HJ, Ulsperger A, Wimmer A, Wewalka F.

Gastroenterology. 2000 Nov;119(5):1191-202. Erratum in: Gastroenterology 2000 Dec;119(6):1809.

PMID:
11054376
10.

Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection.

Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdörfer E, Stolte M.

Blood. 2000 Jun 15;95(12):4014-5. No abstract available.

11.

Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies.

Isaacson PG, Diss TC, Wotherspoon AC, Barbazza R, De Boni M, Doglioni C.

Gastroenterology. 1999 Sep;117(3):750-1. No abstract available.

PMID:
10490369
12.

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.

Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, McLaughlin PW, Rodriguez MA, Romaguera JE, Sarris AH, Younes A, Luthra R, Manning JT, Johnson CM, Lahoti S, Shen Y, Lee JE, Winn RJ, Genta RM, Graham DY, Cabanillas FF.

Ann Intern Med. 1999 Jul 20;131(2):88-95.

PMID:
10419446
13.

Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.

Nobre-Leitão C, Lage P, Cravo M, Cabeçadas J, Chaves P, Alberto-Santos A, Correia J, Soares J, Costa-Mira F.

Am J Gastroenterol. 1998 May;93(5):732-6.

PMID:
9625118
14.

Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.

Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H, Kraemer W, Boersch G, Rohde P, Seifert E, Stolte M, Bayerdoerffer E.

Gastroenterology. 1997 Oct;113(4):1087-90.

PMID:
9322502
15.

Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wündisch T, Ehninger G, Stolte M, Bayerdörffer E.

J Natl Cancer Inst. 1997 Sep 17;89(18):1350-5.

PMID:
9308704
16.

MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein.

Eck M, Schmausser B, Haas R, Greiner A, Czub S, Müller-Hermelink HK.

Gastroenterology. 1997 May;112(5):1482-6.

PMID:
9136825
18.

Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis.

Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Müller-Hermelink HK.

Lab Invest. 1994 Apr;70(4):572-8.

PMID:
8176897
19.

Helicobacter pylori infection and gastric lymphoma.

Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD.

N Engl J Med. 1994 May 5;330(18):1267-71.

20.

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG.

Lancet. 1993 Sep 4;342(8871):575-7.

PMID:
8102719

Supplemental Content

Support Center